Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.